Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.66%64.06B | -5.91%276.21B | -6.17%53.09B | 36.67%293.56B | 21.23%88.27B | 33.23%74.87B | 60.61%73.83B | 42.13%56.58B | 2.64%214.79B | 13.06%72.81B |
| Cost of revenue | 19.55%53.65B | -7.61%231.21B | -7.04%44.88B | 37.71%250.24B | 19.53%74.05B | 34.69%63.84B | 66.00%64.07B | 42.95%48.28B | 2.29%181.72B | 14.64%61.95B |
| Gross profit | 26.74%10.4B | 3.91%45.01B | -1.13%8.21B | 30.97%43.31B | 30.91%14.22B | 25.37%11.04B | 32.37%9.76B | 37.52%8.3B | 4.61%33.07B | 4.82%10.86B |
| Operating expense | 13.77%6.42B | 7.97%27.03B | 12.54%5.64B | 16.40%25.04B | 22.18%8.06B | 18.53%6.34B | 13.82%5.62B | 8.43%5.01B | -3.03%21.51B | 1.43%6.6B |
| Staff costs | ---- | 3.20%12.4B | ---- | 25.78%12.01B | ---- | ---- | ---- | ---- | -0.24%9.55B | ---- |
| Selling and administrative expenses | ---- | 16.29%1.6B | ---- | 26.03%1.38B | ---- | ---- | ---- | ---- | 20.95%1.09B | ---- |
| -General and administrative expense | ---- | 16.29%1.6B | ---- | 26.03%1.38B | ---- | ---- | ---- | ---- | 20.95%1.09B | ---- |
| Depreciation and amortization | ---- | 18.08%1.87B | ---- | -22.45%1.58B | ---- | ---- | ---- | ---- | -20.31%2.04B | ---- |
| -Depreciation | ---- | 24.32%1.37B | ---- | -30.42%1.1B | ---- | ---- | ---- | ---- | -26.47%1.58B | ---- |
| -Amortization | ---- | 3.93%503M | ---- | 4.76%484M | ---- | ---- | ---- | ---- | 11.59%462M | ---- |
| Rent and land expenses | ---- | 7.06%1.38B | ---- | -2.50%1.29B | ---- | ---- | ---- | ---- | -19.49%1.32B | ---- |
| Other operating expenses | ---- | 11.51%9.79B | ---- | 16.95%8.78B | ---- | ---- | ---- | ---- | 0.03%7.5B | ---- |
| Operating profit | 55.28%3.98B | -1.65%17.98B | -21.99%2.57B | 58.06%18.28B | 44.42%6.16B | 35.97%4.7B | 69.98%4.14B | 132.70%3.29B | 22.57%11.56B | 10.53%4.26B |
| Net non-operating interest income (expenses) | -48.57%72M | -26.94%480M | 59.09%140M | 281.98%657M | 80.87%208M | 733.33%175M | 431.43%186M | 8,700.00%88M | 490.91%172M | 394.87%115M |
| Non-operating interest income | -19.02%166M | -12.93%781M | 44.37%205M | 176.85%897M | 77.22%280M | 285.48%239M | 227.78%236M | 343.75%142M | 25.10%324M | 77.53%158M |
| Non-operating interest expense | 44.62%94M | 25.42%301M | 20.37%65M | 57.89%240M | 67.44%72M | 56.10%64M | 35.14%50M | 74.19%54M | -49.83%152M | -66.41%43M |
| Net investment income | -10.87%82M | 79.66%1.07B | 513.33%92M | -37.63%595M | 362.50%74M | -8.22%335M | -46.73%171M | -94.05%15M | -15.80%954M | -94.27%16M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -24.60%2.39B | -47.15%919M | 74.01%3.17B | 2,080.70%1.24B | 0 | -77.44%185M | 176.03%1.74B | 54.63%1.82B | 50.00%57M |
| Income from associates and other participating interests | 95.59%-3M | -86.36%3M | -283.78%-68M | 833.33%22M | -61.22%38M | -82.35%-31M | 24.14%-22M | 167.27%37M | 90.63%-3M | 5,000.00%98M |
| Special income (charges) | -300.00%-2M | -18,277.78%-3.31B | -75.00%1M | 99.20%-18M | 95.98%-26M | 250.00%3M | 103.45%1M | 100.25%4M | -45,320.00%-2.26B | -1,897.22%-647M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --2.46B | --0 |
| Less:Other special charges | ---- | -277.78%-32M | 75.00%-1M | 102.14%18M | 420.00%26M | -142.86%-3M | -103.23%-1M | 99.55%-4M | -16,740.00%-842M | 113.89%5M |
| Less:Write off | --2M | --3.34B | --0 | --0 | --0 | --0 | --0 | --0 | --642M | --642M |
| Other non-operating income (expenses) | -56.04%40M | 33.98%414M | -32.09%91M | -3.44%309M | 291.11%86M | -64.47%27M | -72.81%62M | 119.67%134M | -3.90%320M | -151.72%-45M |
| Income before tax | 11.70%4.17B | -17.31%19.02B | -29.58%3.74B | 83.17%23B | 101.92%7.77B | 23.60%5.2B | 24.93%4.73B | 637.83%5.31B | 4.63%12.56B | -9.44%3.85B |
| Income tax | -19.64%904M | 4.25%6.51B | -33.98%1.13B | 67.98%6.24B | 140.22%1.73B | 7.96%1.26B | 22.33%1.55B | 202.13%1.7B | -5.49%3.72B | -21.20%721M |
| Net income | 25.20%3.27B | -25.34%12.51B | -27.47%2.61B | 89.56%16.76B | 93.03%6.04B | 29.69%3.94B | 26.23%3.18B | 2,222.58%3.6B | 9.58%8.84B | -6.18%3.13B |
| Net income continuous operations | 25.20%3.27B | -25.34%12.51B | -27.49%2.61B | 89.56%16.76B | 93.09%6.04B | 29.62%3.94B | 26.23%3.18B | 2,223.23%3.6B | 9.57%8.84B | -6.21%3.13B |
| Noncontrolling interests | 150.88%429M | 28.46%1.49B | 557.69%171M | 25.11%1.16B | 124.41%662M | -14.57%340M | -32.98%128M | -35.00%26M | 12.68%924M | -42.27%295M |
| Net income attributable to the company | 16.44%2.84B | -29.33%11.03B | -31.76%2.44B | 97.07%15.6B | 89.70%5.38B | 36.36%3.6B | 31.10%3.05B | 3,007.83%3.57B | 9.23%7.92B | 0.35%2.83B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.44%2.84B | -29.33%11.03B | -31.76%2.44B | 97.07%15.6B | 89.70%5.38B | 36.36%3.6B | 31.10%3.05B | 3,007.83%3.57B | 9.23%7.92B | 0.35%2.83B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 18.00%43.93 | -28.19%169.44 | -30.78%37.23 | 101.15%235.97 | 93.51%81.8941 | 39.62%54.585 | 34.43%45.97 | 3,063.82%53.785 | 10.31%117.31 | 2.16%42.32 |
| Diluted earnings per share | 18.00%43.93 | -28.19%169.44 | -30.78%37.23 | 101.15%235.97 | 93.51%81.8941 | 39.62%54.585 | 34.09%45.8523 | 3,063.82%53.785 | 10.31%117.31 | 2.16%42.32 |
| Dividend per share | 0 | 9.92%72 | 0 | 8.26%65.5 | 14.08%40.5 | 0 | 0.00%25 | 0 | 21.00%60.5 | 1.43%35.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |